5 items found in 1 pages
Professor Sam Janes - Detecting lung cancer earlier: Crawling to the SUMMIT
Professor Sam Janes Wellcome Trust Senior Fellow in Clinical Science; Professor of Respiratory Medicine, UCL Respiratory Head, Respiratory Research Dept, UCL Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 Cancer detection: the earlier the better? Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
639
6/4/2019
Professor Caroline Moore - Prostate cancer detection - benefits and harms of early detection
Professor Caroline Moore Head of Urology, UCL Honorary Consultant Urologist, UCLH Trust Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 Cancer detection: the earlier the better? Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
610
6/4/2019
Dr Claire Roddie - Cellular Immunotherapy for Cancer: better targets, better targeting
Dr Claire Roddie Consultant Haematologist; Honorary Senior Lecturer in Haematology, UCL Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 The cancer treatment revolution and how we afford it? Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
853
6/4/2019
Professor Marcel Levi - New cancer drugs in the 21st century: an acceptable bang for your buck?
Professor Marcel Levi Chief Executive, UCLH and Professor of Medicine, UCL Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 The cancer treatment revolution and how we afford it? Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
648
6/4/2019
Professor Charles Swanton - Cancer evolution, immune evasion and metastatic progression - insights from TRACERx
Prof Charles Swanton UCL Cancer Institute & The Francis Crick Institute Director, CRUK UCL Lung Cancer Centre Rethinking Cancer | UCL Cancer Domain Symposium Monday 13 May 2019 Cancer evolution: can we beat Nature? Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology. This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
682
6/3/2019